F. Bassissi, A. Lespine, and M. Alvinerie, Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006.
DOI : 10.1248/bpb1978.4.879

J. P. Benoit, F. Courteille, and C. Thies, A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres, International Journal of Pharmaceutics, vol.29, issue.2-3, pp.95-102, 1986.
DOI : 10.1016/0378-5173(86)90106-7

R. Bodmeier and H. Chen, Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen, Journal of Controlled Release, vol.10, issue.2, pp.167-175, 1989.
DOI : 10.1016/0168-3659(89)90059-X

R. Bodmeier and J. W. Mcginity, Solvent selection in the preparation of poly, 1988.

L. Brannon-peppas, Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery, International Journal of Pharmaceutics, vol.116, issue.1, pp.1-9, 1995.
DOI : 10.1016/0378-5173(94)00324-X

S. Chhabra, V. Sachdeva, and S. Singh, Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system, International Journal of Pharmaceutics, vol.342, issue.1-2, pp.72-77, 2007.
DOI : 10.1016/j.ijpharm.2007.04.034

S. L. Clark, A. J. Crowley, P. G. Schmidt, A. R. Donoghue, and C. A. Piche, Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004.
DOI : 10.2460/ajvr.2004.65.752

M. Dunne, I. Corrigan, and Z. Ramtoola, Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, vol.21, issue.16, pp.1659-1668, 2000.
DOI : 10.1016/S0142-9612(00)00040-5

A. Frank, S. K. Rath, and S. S. Venkatraman, Controlled release from bioerodible polymers: effect of drug type and polymer composition, Journal of Controlled Release, vol.102, issue.2, pp.333-344, 2005.
DOI : 10.1016/j.jconrel.2004.10.019

S. Freiberg and X. X. Zhu, Polymer microspheres for controlled drug release, International Journal of Pharmaceutics, vol.282, issue.1-2, pp.1-18, 2004.
DOI : 10.1016/j.ijpharm.2004.04.013

C. Gokbulut, U. Karademir, M. Boyacioglu, and Q. A. Mckellar, Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006.
DOI : 10.1016/j.vetpar.2005.10.002

G. Canga, A. , S. Prieto, A. M. Jose-diez-liebana, M. Martinez et al., The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009.
DOI : 10.1016/j.tvjl.2007.07.011

A. S. Hasan, M. Socha, A. Lamprecht, F. E. Ghazouani, A. Sapin et al., Effect of the microencapsulation of nanoparticles on the reduction of burst release, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.53-61, 2007.
DOI : 10.1016/j.ijpharm.2007.05.066

A. G. Hausberger and P. P. Deluca, Characterization of biodegradable poly(d,l-lactide-co-glycolide) polymers and microspheres, Journal of Pharmaceutical and Biomedical Analysis, vol.13, issue.6, pp.747-760, 1995.
DOI : 10.1016/0731-7085(95)01276-Q

D. R. Hennessy, Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds, Veterinary Parasitology, vol.72, issue.3-4, pp.367-382, 1997.
DOI : 10.1016/S0304-4017(97)00106-4

J. Herrmann and R. Bodmeier, The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method, Journal of Controlled Release, vol.36, issue.1-2, pp.63-71, 1995.
DOI : 10.1016/0168-3659(95)00051-9

S. Jaraswekin, S. Prakongpan, and R. Bodmeier, Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles, Journal of Microencapsulation, vol.19, issue.2, pp.117-128, 2007.
DOI : 10.1023/A:1015168301339

J. E. Kim, S. R. Kim, S. H. Lee, C. H. Lee, and D. D. Kim, The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix, International Journal of Pharmaceutics, vol.201, issue.1, pp.29-36, 2000.
DOI : 10.1016/S0378-5173(00)00388-4

D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann, How porosity and size affect the drug release mechanisms from PLGA-based microparticles, International Journal of Pharmaceutics, vol.314, issue.2, pp.198-206, 2006.
DOI : 10.1016/j.ijpharm.2005.07.031

T. Alfrey, The influence of solvent composition on the specific viscosities of polymer solutions, Journal of Colloid Science, vol.2, issue.1, pp.99-114, 1947.
DOI : 10.1016/0095-8522(47)90013-5

J. M. Anderson and M. S. Shive, Biodegradation and biocompatibility of PLA and PLGA microspheres, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.5-24, 1997.
DOI : 10.1016/S0169-409X(97)00048-3

K. J. Brodbeck, J. R. Desnoyer, and A. J. Mchugh, Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999.
DOI : 10.1016/S0168-3659(99)00159-5

C. M. Deadman, I. W. Kellaway, M. Yasin, P. A. Dickinson, and S. Murdan, An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots, Journal of Controlled Release, vol.122, issue.1, pp.79-85, 2007.
DOI : 10.1016/j.jconrel.2007.06.013

W. Y. Dong, M. Körber, V. Lopez-esguerra, and R. Bodmeier, Stability of poly(d,l-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems, Journal of Controlled Release, vol.115, issue.2, pp.158-167, 2006.
DOI : 10.1016/j.jconrel.2006.07.013

R. L. Dunn, J. P. English, D. R. Cowsar, and D. P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, p.763, 1990.

C. Gokbulut, U. Karademir, M. Boyacioglu, and Q. A. Mckellar, Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006.
DOI : 10.1016/j.vetpar.2005.10.002

G. Canga, A. , S. Prieto, A. M. Jose-diez-liebana, M. Martinez et al., The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009.
DOI : 10.1016/j.tvjl.2007.07.011

P. D. Graham, K. J. Brodbeck, and A. J. Mchugh, Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.58, issue.2, pp.233-245, 1999.
DOI : 10.1016/S0168-3659(98)00158-8

C. M. Hansen, The three dimensional solubility parameter-key to paint component affinities: II and III, J. Paint Technol, vol.39, pp.505-514, 1967.

C. M. Hansen, Hansen solubility parameters, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01639526

A. Hatefi and B. Amsden, Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002.
DOI : 10.1016/S0168-3659(02)00008-1

M. L. Huggins, The Viscosity of Dilute Solutions of Long-Chain Molecules. IV. Dependence on Concentration, Journal of the American Chemical Society, vol.64, issue.11, pp.2716-2718, 1942.
DOI : 10.1021/ja01263a056

R. A. Jain, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, vol.21, issue.23, pp.2475-2490, 2000.
DOI : 10.1016/S0142-9612(00)00115-0

S. Kempe, H. Metz, and K. Mäder, Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process, Journal of Controlled Release, vol.130, issue.3, pp.220-225, 2008.
DOI : 10.1016/j.jconrel.2008.06.006

M. Körber and R. Bodmeier, Development of an in situ forming PLGA drug delivery system, European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.283-292, 2008.
DOI : 10.1016/j.ejps.2008.07.007

H. Kranz and R. Bodmeier, Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008.
DOI : 10.1016/j.ejps.2008.03.004

W. J. Lambert and K. D. Peck, Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins, Journal of Controlled Release, vol.33, issue.1, pp.189-195, 1995.
DOI : 10.1016/0168-3659(94)00083-7

F. Bassissi, A. Lespine, and M. Alvinerie, Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006.
DOI : 10.1248/bpb1978.4.879

K. J. Brodbeck, J. R. Desnoyer, and A. J. Mchugh, Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999.
DOI : 10.1016/S0168-3659(99)00159-5

J. A. Camargo, A. Sapin, D. Daloz, and P. Maincent, Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables Journal of microencapsulation, 2010.

S. L. Clark, A. J. Crowley, P. G. Schmidt, A. R. Donoghue, and C. A. Piche, Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004.
DOI : 10.2460/ajvr.2004.65.752

. Collie-online, Mdr1: Quand la génétique s'en mêle, 2010.

S. S. Dadarkar, M. D. Deore, and M. M. Gatne, Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats, Regulatory Toxicology and Pharmacology, vol.47, issue.3, pp.257-260, 2007.
DOI : 10.1016/j.yrtph.2006.10.009

D. Montigny, P. Shim, J. S. Pivnichny, and J. V. , Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent, Journal of Pharmaceutical and Biomedical Analysis, vol.8, issue.6, pp.507-511, 1990.
DOI : 10.1016/0731-7085(90)80060-3

R. L. Dunn, J. P. English, D. R. Cowsar, and D. P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, US Patent, vol.4, p.938763, 1990.

G. Edwards, Ivermectin: does P-glycoprotein play a role in neurotoxicity?, Filaria Journal, pp.1-6, 2003.

G. Canga, A. , S. Prieto, A. M. Jose-diez-liebana, M. Martinez et al., The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009.
DOI : 10.1016/j.tvjl.2007.07.011

A. S. Hasan, M. Socha, A. Lamprecht, F. E. Ghazouani, A. Sapin et al., Effect of the microencapsulation of nanoparticles on the reduction of burst release, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.53-61, 2007.
DOI : 10.1016/j.ijpharm.2007.05.066

A. Hatefi and B. Amsden, Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002.
DOI : 10.1016/S0168-3659(02)00008-1

W. Im-emsap, Dissertation: In vitro and in vivo properties of injectable biodegradable in situ forming microparticle systmes, Faculty of Biology, 2002.

H. Kranz and R. Bodmeier, A novel in situ forming drug delivery system for controlled parenteral drug delivery, International Journal of Pharmaceutics, vol.332, issue.1-2, pp.107-114, 2007.
DOI : 10.1016/j.ijpharm.2006.09.033

H. Kranz and R. Bodmeier, Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008.
DOI : 10.1016/j.ejps.2008.03.004

A. Lifschitz, G. Virkel, A. Pis, F. Imperiale, S. Sanchez et al., Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle, Veterinary Parasitology, vol.86, issue.3, pp.203-215, 1999.
DOI : 10.1016/S0304-4017(99)00142-9

X. Liu, Q. Sun, H. Wang, L. Zhang, and J. Y. Wang, Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials, vol.26, issue.1, pp.109-115, 2005.
DOI : 10.1016/j.biomaterials.2004.02.013

D. Loffler and T. A. Ternes, Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography???tandem mass spectrometry, Journal of Chromatography A, vol.1021, issue.1-2, pp.133-144, 2003.
DOI : 10.1016/j.chroma.2003.08.089

X. Luan and R. Bodmeier, In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters, European Journal of Pharmaceutical Sciences, vol.27, issue.2-3, pp.143-149, 2006.
DOI : 10.1016/j.ejps.2005.09.002

X. Luan and R. Bodmeier, Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems, Journal of Controlled Release, vol.110, issue.2, pp.266-272, 2006.
DOI : 10.1016/j.jconrel.2005.10.005

H. Maeda, M. Brandon, and A. Sano, Design of controlled-release formulation for ivermectin using silicone, International Journal of Pharmaceutics, vol.261, issue.1-2, pp.9-19, 2003.
DOI : 10.1016/S0378-5173(03)00293-X

J. A. Miller, R. B. Davey, D. D. Oehler, J. M. Pound, J. E. George et al., Control of Boophilus annulatus (Acari: Ixodidae) on Cattle Using Injectable Microspheres Containing Ivermectin, Journal of Economic Entomology, vol.92, issue.5, pp.1142-1146, 1999.
DOI : 10.1093/jee/92.5.1142

J. A. Miller, D. D. Oehler, and J. M. Pound, Delivery of Ivermectin by Injectable Microspheres, Journal of Economic Entomology, vol.91, issue.3, pp.655-659, 1998.
DOI : 10.1093/jee/91.3.655

A. R. Ahmed, A. Dashevsky, and R. Bodmeier, Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.3, pp.375-380, 2010.
DOI : 10.1016/j.ejpb.2010.04.004

I. Ahmed and K. Kasraian, Pharmaceutical challenges in veterinary product development, Advanced Drug Delivery Reviews, vol.54, issue.6, 2002.
DOI : 10.1016/S0169-409X(02)00074-1

T. Alfrey, The influence of solvent composition on the specific viscosities of polymer solutions, Journal of Colloid Science, vol.2, issue.1, pp.99-114, 1947.
DOI : 10.1016/0095-8522(47)90013-5

M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer, Biodegradable microspheres as controlled-release tetanus toxoid delivery systems, Vaccine, vol.12, issue.4, pp.299-306, 1994.
DOI : 10.1016/0264-410X(94)90092-2

G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-420, 1995.
DOI : 10.1023/A:1016212804288

J. M. Anderson and M. S. Shive, Biodegradation and biocompatibility of PLA and PLGA microspheres, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.5-24, 1997.
DOI : 10.1016/S0169-409X(97)00048-3

D. Y. Arifin, L. Y. Lee, and C. H. Wang, Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems, Advanced Drug Delivery Reviews, vol.58, issue.12-13, pp.1274-1325, 2006.
DOI : 10.1016/j.addr.2006.09.007

J. W. Bailey, R. L. Barker, and M. D. Karlstad, Total Parenteral Nutrition with Short- and Long-Chain Triglycerides: Triacetin Improves Nitrogen Balance in Rats, The Journal of Nutrition, vol.122, issue.9, pp.1823-1829, 1992.
DOI : 10.1093/jn/122.9.1823

A. F. Barton, Handbook of solubility parameters and other cohesion parameters, 1991.

F. Bassissi, A. Lespine, and M. Alvinerie, Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research, vol.4, issue.Suppl 1, pp.244-249, 2006.
DOI : 10.1248/bpb1978.4.879

C. Bastioli, Handbook of biodegradable polymers, Rapra Technology, p.540, 2005.

R. Bhardwaj and J. Blanchard, In vitro evaluation of Poly(d,l-lactide-co-glycolide) polymer-based implants containing the ??-melanocyte stimulating hormone analog, Melanotan-I, Journal of Controlled Release, vol.45, issue.1, pp.49-55, 1997.
DOI : 10.1016/S0168-3659(96)01544-1

P. Blasi, S. S. Souza, F. Selmin, P. P. Deluca, B. Bleiberg et al., Plasticizing effect of water on poly(lactide-co-glycolide) Metabolism of triacetin-derived acetate in dogs, Journal of Controlled Release American Journal of Clinical Nutrition, vol.1089, issue.58, pp.908-911, 1993.

R. Bodmeier and H. Chen, Preparation of Biodegradable Poly(??)lactide Microparticles Using a Spray-Drying Technique, Journal of Pharmacy and Pharmacology, vol.63, issue.11, pp.754-757, 1988.
DOI : 10.1002/jps.2600630325

R. Bodmeier and H. Chen, Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen, Journal of Controlled Release, vol.10, issue.2, pp.167-175, 1989.
DOI : 10.1016/0168-3659(89)90059-X

R. Bodmeier and H. G. Chen, Evaluation of Biodegradable Poly(lactide) Pellets Prepared by Direct Compression, Journal of Pharmaceutical Sciences, vol.78, issue.10, pp.819-822, 1989.
DOI : 10.1002/jps.2600781008

R. Bodmeier and J. W. Mcginity, The preparation and evaluation of drug-containing poly(dllactide ) microspheres formed by the solvent evaporation method, Pharmaceutical Research, vol.04, issue.6, pp.465-471, 1987.
DOI : 10.1023/A:1016419303727

R. Bodmeier and J. W. Mcginity, Solvent selection in the preparation of poly, 1988.

D. Bodmer, T. Kissel, and E. Traechslin, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems, Journal of Controlled Release, vol.21, issue.1-3, pp.129-138, 1992.
DOI : 10.1016/0168-3659(92)90014-I

M. Boisdron-celle, P. Menei, and J. P. Benoit, Preparation and Characterization of 5-Fluorouracil-loaded Microparticles as Biodegradable Anticancer Drug Carriers, Journal of Pharmacy and Pharmacology, vol.7, issue.2, pp.108-114, 1995.
DOI : 10.1016/0168-3659(88)90054-5

L. Brannon-peppas, Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery, International Journal of Pharmaceutics, vol.116, issue.1, pp.1-9, 1995.
DOI : 10.1016/0378-5173(94)00324-X

L. Brannon-peppas and M. Vert, Polylactic and polyglicolic acids as drug delivery carriers, 2000.

D. L. Wise, Handbook of Pharmaceutical Controlled Release Technology, pp.99-130

K. J. Brodbeck, J. R. Desnoyer, and A. J. Mchugh, Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.62, issue.3, pp.333-344, 1999.
DOI : 10.1016/S0168-3659(99)00159-5

K. J. Brodbeck, A. T. Gaynor-duarte, T. , and S. T. , Alza Corporation. Gel composition and methods, US Patent 6, 2000.

D. J. Burgess, A. S. Hussain, T. S. Ingallinera, and M. L. Chen, Assuring quality and performance of sustained and controlled release parenterals, European Journal of Pharmaceutical Sciences, vol.21, issue.5, pp.1761-1768, 2002.
DOI : 10.1016/j.ejps.2004.03.001

F. V. Burkersroda, L. Schedl, and A. Göpferich, Why degradable polymers undergo surface erosion or bulk erosion, Biomaterials, vol.23, issue.21, pp.4221-4231, 2002.
DOI : 10.1016/S0142-9612(02)00170-9

R. L. Carrier, L. A. Miller, and I. Ahmed, The utility of cyclodextrins for enhancing oral bioavailability, Journal of Controlled Release, vol.123, issue.2, pp.78-99, 2007.
DOI : 10.1016/j.jconrel.2007.07.018

M. Cavalier, J. P. Benoit, and C. Thies, The formation and characterization of hydrocortisone-loaded poly((??)-lactide) microspheres, Journal of Pharmacy and Pharmacology, vol.10, issue.4, pp.249-253, 1986.
DOI : 10.1002/pol.1972.160100706

C. M. Chang and R. Bodmeier, Swelling of and Drug Release from Monoglyceride-Based Drug Delivery Systems, Journal of Pharmaceutical Sciences, vol.86, issue.6, pp.747-752, 1997.
DOI : 10.1021/js960256w

G. Chen and G. Junnarkar, Alzamer Depot bioerodible polymer technology, 2008.

R. Chern and J. R. Zingerman, Liquid polymeric compositions for controlled release of bioactive substances. WO patent 9947073, 1999.

S. Chhabra, V. Sachdeva, and S. Singh, Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system, International Journal of Pharmaceutics, vol.342, issue.1-2, pp.72-77, 2007.
DOI : 10.1016/j.ijpharm.2007.04.034

S. L. Clark, A. J. Crowley, P. G. Schmidt, A. R. Donoghue, and C. A. Piche, Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs, American Journal of Veterinary Research, vol.65, issue.6, pp.752-757, 2004.
DOI : 10.2460/ajvr.2004.65.752

B. R. Conway and H. Oya-alpar, Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: Effect of emulsifier on the microsphere characteristics and release kinetics, European Journal of Pharmaceutics and Biopharmaceutics, vol.42, pp.42-48, 1996.

P. Couvreur and F. Puisieux, Nano- and microparticles for the delivery of polypeptides and proteins, Advanced Drug Delivery Reviews, vol.10, issue.2-3, pp.141-162, 1993.
DOI : 10.1016/0169-409X(93)90046-7

D. R. Cowsar, T. R. Tice, R. M. Gilley, and J. P. English, [8] Poly(lactide-co-glycolide) microcapsules for controlled release of steroids, Methods in Enzymology, vol.112, pp.101-116, 1985.
DOI : 10.1016/S0076-6879(85)12010-0

D. Rosa, G. Quaglia, F. , L. Rotonda, M. I. Besnard et al., Biodegradable microparticles for the controlled delivery of oligonucleotides, International Journal of Pharmaceutics, vol.242, issue.1-2, pp.225-228, 2002.
DOI : 10.1016/S0378-5173(02)00162-X

W. Y. Dong, M. Körber, V. Lopez-esguerra, and R. Bodmeier, Stability of poly(d,l-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems, Journal of Controlled Release, vol.115, issue.2, pp.158-167, 2006.
DOI : 10.1016/j.jconrel.2006.07.013

C. Dubernet, Thermoanalysis of microspheres, Thermochimica Acta, vol.248, pp.259-269, 1995.
DOI : 10.1016/0040-6031(94)01947-F

R. L. Dunn, J. P. English, D. R. Cowsar, and D. P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, US Patent, vol.4, p.938763, 1990.

R. L. Dunn, J. P. English, D. R. Cowsar, and D. P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, p.201, 1994.

R. L. Dunn, J. P. English, D. R. Cowsar, and D. P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, p.739176, 1998.

R. L. Dunn and A. J. Tipton, Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants, p.716, 1997.

M. Dunne, I. Corrigan, and Z. Ramtoola, Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, vol.21, issue.16, pp.1659-1668, 2000.
DOI : 10.1016/S0142-9612(00)00040-5

L. Dwan-'isa, M. Dinguizli, V. Préat, A. Ariën, and M. Brewster, Qualitative predictions of solubilization of highly hydrophobic drugs in block copolymer micelles, 2005.

R. Eliaz and J. Kost, Composition and method for forming biodegradable implants in situ and uses of these implants. WO Patent 9742987, 1997.

R. E. Eliaz and J. Kost, Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins, Journal of Biomedical Materials Research, vol.22, issue.3, pp.388-396, 2000.
DOI : 10.1002/aic.690180523

R. E. Eliaz and F. C. Szoka-jr, Robust and prolonged gene expression from injectable polymeric implants, Gene Therapy, vol.6, issue.18, pp.1230-1237, 2002.
DOI : 10.1038/sj.gt.3300929

URL : http://www.nature.com/gt/journal/v9/n18/pdf/3301786a.pdf

R. E. Eliaz, D. Wallach, and J. Kost, Delivery of soluble tumor necrosis factor receptor from insitu forming PLGA implants: In vivo, Pharmaceutical Research, vol.17, issue.12, pp.1546-1550, 2000.
DOI : 10.1023/A:1007621512647

S. Engstrom and L. Engstrom, Phase behaviour of the lidocaine-monoolein-water system, International Journal of Pharmaceutics, vol.79, issue.1-3, pp.113-122, 1992.
DOI : 10.1016/0378-5173(92)90102-8

N. Erden and N. Celebi, Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique, International Journal of Pharmaceutics, vol.137, issue.1, pp.57-66, 1996.
DOI : 10.1016/0378-5173(96)04454-7

N. Faisant, J. Siepmann, and J. P. Benoit, PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release, European Journal of Pharmaceutical Sciences, vol.15, issue.4, pp.355-366, 2002.
DOI : 10.1016/S0928-0987(02)00023-4

J. Folkman and D. M. Long, The use of silicone rubber as a carrier for prolonged drug therapy, Journal of Surgical Research, vol.4, issue.3, pp.139-142, 1964.
DOI : 10.1016/S0022-4804(64)80040-8

J. Folkman, L. Jr, D. M. Rosenbaum, and R. , Silicone Rubber: A New Diffusion Property Useful for General Anesthesia, Science, vol.154, issue.3745, pp.148-149, 1966.
DOI : 10.1126/science.154.3745.148

. Fort-dodge, Risk minimization action plan (RiskMAP) for: PROHEART® 6 (moxidectin), 2008.

. U. Sustained-release-injectable-for-dogs and . Fda, ) Doc. [En ligne]-Adresse URL : http://www.fda.gov, 2010.

. Fort-dodge, Guardian SR. Fort Dodge Animal Health, 2010.

A. Frank, S. K. Rath, and S. S. Venkatraman, Controlled release from bioerodible polymers: effect of drug type and polymer composition, Journal of Controlled Release, vol.102, issue.2, pp.333-344, 2005.
DOI : 10.1016/j.jconrel.2004.10.019

S. Freiberg and X. X. Zhu, Polymer microspheres for controlled drug release, International Journal of Pharmaceutics, vol.282, issue.1-2, pp.1-18, 2004.
DOI : 10.1016/j.ijpharm.2004.04.013

S. Freitas, H. P. Merkle, and B. Gander, Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology, Journal of Controlled Release, vol.102, issue.2, pp.313-332, 2005.
DOI : 10.1016/j.jconrel.2004.10.015

T. Freytag, A. Dashevsky, L. Tillman, G. E. Hardee, and R. Bodmeier, Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, Journal of Controlled Release, vol.69, issue.1, pp.197-207, 2000.
DOI : 10.1016/S0168-3659(00)00299-6

K. Fu, D. W. Pack, A. M. Klibanov, and R. Langer, Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres, Pharmaceutical Research, vol.17, issue.1, pp.100-106, 2000.
DOI : 10.1023/A:1007582911958

E. D. Gamsiz, L. Miller, A. G. Thombre, I. Ahmed, and R. L. Carrier, Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development, Biotechnology and Bioengineering, vol.536, issue.1??????3, pp.409-420, 2010.
DOI : 10.1248/bpb1978.6.124

Z. Gao, A. J. Shukla, J. R. Johnson, and W. R. Crowley, Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: In vitro evaluation, Pharmaceutical Research, vol.12, issue.6, pp.857-863, 1995.
DOI : 10.1023/A:1016209020160

Z. H. Gao, W. R. Crowley, A. J. Shukla, J. R. Johnson, and J. F. Reger, Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: In vivo evaluation, Pharmaceutical Research, vol.12, issue.6, pp.864-868, 1995.
DOI : 10.1023/A:1016261004230

T. G. Geary, Ivermectin 20 years on: maturation of a wonder drug, Trends in Parasitology, vol.21, issue.11, pp.530-532, 2005.
DOI : 10.1016/j.pt.2005.08.014

A. A. Ghahremankhani, F. Dorkoosh, and R. Dinarvand, PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery, Polymer Bulletin, vol.59, issue.5, pp.637-646, 2007.
DOI : 10.1007/s00289-007-0807-4

L. T. Glickman, N. W. Glickman, G. E. Moore, R. Cobb, S. A. Connell et al., Safety Profile of Moxidectin (ProHeart 6) and Two Oral Heartworm Preventives in Dogs, International Journal of Applied Research in Veterinary Medicine, vol.3, issue.2, 2005.

C. Gokbulut, U. Karademir, M. Boyacioglu, and Q. A. Mckellar, Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs, Veterinary Parasitology, vol.135, issue.3-4, 2006.
DOI : 10.1016/j.vetpar.2005.10.002

G. Canga, A. , S. Prieto, A. M. Jose-diez-liebana, M. Martinez et al., The pharmacokinetics and metabolism of ivermectin in domestic animal species, The Veterinary Journal, vol.179, issue.1, pp.25-37, 2009.
DOI : 10.1016/j.tvjl.2007.07.011

A. Göpferich, Mechanisms of polymer degradation and erosion, Biomaterials, vol.17, issue.2, pp.103-114, 1996.
DOI : 10.1016/0142-9612(96)85755-3

A. Göpferich, Polymer Bulk Erosion, Macromolecules, vol.30, issue.9, pp.2598-2604, 1997.
DOI : 10.1021/ma961627y

P. D. Graham, K. J. Brodbeck, and A. J. Mchugh, Phase inversion dynamics of PLGA solutions related to drug delivery, Journal of Controlled Release, vol.58, issue.2, pp.233-245, 1999.
DOI : 10.1016/S0168-3659(98)00158-8

I. Grizzi, H. Garreau, S. Li, and M. Vert, Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence, Biomaterials, vol.16, issue.4, pp.305-311, 1995.
DOI : 10.1016/0142-9612(95)93258-F

C. M. Hansen, The three dimensional solubility parameter-key to paint component affinities: II and III, Journal of paint technology, vol.39, pp.505-514, 1967.

C. M. Hansen, Polymer additives and solubility parameters, Progress in Organic Coatings, vol.51, issue.2, pp.109-112, 2004.
DOI : 10.1016/j.porgcoat.2004.05.003

C. M. Hansen, Hansen solubility parameters: A user's handbook, 2007.
DOI : 10.1201/9781420049312

A. Hatefi and B. Amsden, Biodegradable injectable in situ forming drug delivery systems, Journal of Controlled Release, vol.80, issue.1-3, 2002.
DOI : 10.1016/S0168-3659(02)00008-1

M. Havlicek, R. S. Straw, V. Langova, and W. S. Dernell, Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas, Veterinary and Comparative Oncology, vol.14, issue.2, pp.122-129, 2009.
DOI : 10.1111/j.1939-1676.2000.tb02279.x

D. R. Hennessy, Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds, Veterinary Parasitology, vol.72, issue.3-4, pp.367-382, 1997.
DOI : 10.1016/S0304-4017(97)00106-4

J. Herrmann and R. Bodmeier, The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method, Journal of Controlled Release, vol.36, issue.1-2, pp.63-71, 1995.
DOI : 10.1016/0168-3659(95)00051-9

B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, J. Richard et al., Lipidic nanocapsules: preparation process and use as Drug Delivery Systems, 2000.

J. H. Hildebrand and R. L. Scott, Regular solutions, 1962.

A. S. Hoffman, The origins and evolution of ???controlled??? drug delivery systems, Journal of Controlled Release, vol.132, issue.3, pp.153-163, 2008.
DOI : 10.1016/j.jconrel.2008.08.012

H. Pérez, M. Zinutti, C. Lamprecht, A. Ubrich, N. Astier et al., The preparation and evaluation of poly(??-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug, Journal of Controlled Release, vol.65, issue.3, pp.429-438, 2000.
DOI : 10.1016/S0168-3659(99)00253-9

L. Houdré, Le traitement des ectoparasitoses des rongers et lagomorphes par les avermectines, Thèse pour le Diplôme, 2003.

S. J. Huang, Poly(Lactic Acid) and Copolyesters Handbook of biodegradable polymers. United Kingdom. Rapra Technology, pp.287-301, 2005.

M. L. Huggins, The Viscosity of Dilute Solutions of Long-Chain Molecules. IV. Dependence on Concentration, Journal of the American Chemical Society, vol.64, issue.11, pp.2716-2718, 1942.
DOI : 10.1021/ja01263a056

N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

W. Im-emsap, Dissertation: In vitro and in vivo properties of injectable biodegradable in situ forming microparticle systmes, Faculty of Biology, 2002.

R. A. Jain, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, vol.21, issue.23, pp.2475-2490, 2000.
DOI : 10.1016/S0142-9612(00)00115-0

R. A. Jain, C. T. Rhodes, A. M. Railkar, A. W. Malick, and N. H. Shah, Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables, European Journal of Pharmaceutics and Biopharmaceutics, vol.50, issue.2, pp.257-262, 2000.
DOI : 10.1016/S0939-6411(00)00062-X

S. Jaraswekin, S. Prakongpan, and R. Bodmeier, Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles, Journal of Microencapsulation, vol.19, issue.2, pp.117-128, 2007.
DOI : 10.1023/A:1015168301339

L. Javot, T. Lecompte, M. Rabiskova, and P. Maincent, Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio, Journal of Controlled Release, vol.139, issue.1, pp.8-14, 2009.
DOI : 10.1016/j.jconrel.2009.05.029

G. Jiang, B. H. Woo, F. Kang, J. Singh, and P. P. Deluca, Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(?,?-lactide-co-glycolide) microspheres, Journal of Controlled Release, vol.79, issue.1-3, pp.137-145, 2002.
DOI : 10.1016/S0168-3659(01)00533-8

P. Johansen, F. Estevez, R. Zurbriggen, H. P. Merkle, R. Glück et al., Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres, Vaccine, vol.19, issue.9-10, pp.1047-1054, 2000.
DOI : 10.1016/S0264-410X(00)00343-1

H. Katou, A. J. Wandrey, and B. Gander, Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication, International Journal of Pharmaceutics, vol.364, issue.1, pp.45-53, 2008.
DOI : 10.1016/j.ijpharm.2008.08.015

T. Kissel, Z. Brich, S. Bantle, I. Lancranjan, F. Nimmerfall et al., Parenteral depot-systems on the basis of biodegradable polyesters, Journal of Controlled Release, vol.16, issue.1-2, pp.27-42, 1991.
DOI : 10.1016/0168-3659(91)90028-C

T. Kissel, S. Maretschke, C. Packhäuser, J. Schnieders, and N. Seidel, Parenteral depot systems and their application in the pharmaceutical industry, 2006.

. Microencapsulation, Methods and industrial application. Boca raton, pp.113-122

D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann, How porosity and size affect the drug release mechanisms from PLGA-based microparticles, International Journal of Pharmaceutics, vol.314, issue.2, pp.198-206, 2006.
DOI : 10.1016/j.ijpharm.2005.07.031

D. Klose, F. Siepmann, K. Elkharraz, and J. Siepmann, PLGA-based drug delivery systems: Importance of the type of drug and device geometry, International Journal of Pharmaceutics, vol.354, issue.1-2, pp.95-103, 2008.
DOI : 10.1016/j.ijpharm.2007.10.030

M. Körber and R. Bodmeier, Development of an in situ forming PLGA drug delivery system, European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.283-292, 2008.
DOI : 10.1016/j.ejps.2008.07.007

H. Kranz and R. Bodmeier, A novel in situ forming drug delivery system for controlled parenteral drug delivery, International Journal of Pharmaceutics, vol.332, issue.1-2, pp.107-114, 2007.
DOI : 10.1016/j.ijpharm.2006.09.033

H. Kranz and R. Bodmeier, Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008.
DOI : 10.1016/j.ejps.2008.03.004

A. Kubin, H. G. Loew, U. Burner, G. Jessner, H. Kolbabek et al., How to make hypericin water-soluble, Pharmazie, vol.63, pp.263-269, 2008.

J. K. Lalla and K. Sapna, Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route, Journal of Microencapsulation, vol.30, issue.4, pp.449-460, 1993.
DOI : 10.1248/cpb.30.3719

W. J. Lambert and K. D. Peck, Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins, Journal of Controlled Release, vol.33, issue.1, pp.189-195, 1995.
DOI : 10.1016/0168-3659(94)00083-7

D. L. Laskin, Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces, Chemical Research in Toxicology, vol.22, issue.8, pp.1376-1385, 2009.
DOI : 10.1021/tx900086v

J. Lee and I. W. Kellaway, In vitro peptide release from liquid crystalline buccal delivery systems, International Journal of Pharmaceutics, vol.195, issue.1-2, pp.29-33, 2000.
DOI : 10.1016/S0378-5173(99)00356-7

N. Leelarasamee, S. A. Howard, and C. J. Malanga, Kinetics of drug release from polylactic acid???hydrocortisone microcapsules, Journal of Microencapsulation, vol.64, issue.3, pp.171-179, 1986.
DOI : 10.1002/jps.2600640124

N. Leelarasamee, S. A. Howard, C. J. Malanga, and J. K. Ma, A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading, Journal of Microencapsulation, vol.23, issue.2, pp.147-157, 1988.
DOI : 10.1016/0020-7292(85)90106-7

P. Legrand, S. Lesieur, A. Bochot, R. Gref, W. Raatjes et al., Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.33-43, 2007.
DOI : 10.1016/j.ijpharm.2007.05.054

URL : https://hal.archives-ouvertes.fr/hal-00180715

D. H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers, 1990.

M. Chasin and R. Langer, Biodegradable polymers as drug delivery systems

M. Li, O. Rouaud, and D. Poncelet, Microencapsulation by solvent evaporation: State of the art for process engineering approaches, International Journal of Pharmaceutics, vol.363, issue.1-2, pp.26-39, 2008.
DOI : 10.1016/j.ijpharm.2008.07.018

L. T. Lim, R. Auras, and M. Rubino, Processing technologies for poly(lactic acid), Progress in Polymer Science, vol.33, issue.8, pp.820-852, 2008.
DOI : 10.1016/j.progpolymsci.2008.05.004

P. Linse and M. Malmsten, Temperature-dependent micellization in aqueous block copolymer solutions, Macromolecules, vol.25, issue.20, pp.5434-5439, 1992.
DOI : 10.1021/ma00046a048

X. Liu, Q. Sun, H. Wang, L. Zhang, and J. Y. Wang, Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials, vol.26, issue.1, pp.109-115, 2005.
DOI : 10.1016/j.biomaterials.2004.02.013

D. Loffler and T. A. Ternes, Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography???tandem mass spectrometry, Journal of Chromatography A, vol.1021, issue.1-2, pp.133-144, 2003.
DOI : 10.1016/j.chroma.2003.08.089

X. Luan and R. Bodmeier, In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters, European Journal of Pharmaceutical Sciences, vol.27, issue.2-3, pp.143-149, 2006.
DOI : 10.1016/j.ejps.2005.09.002

X. Luan and R. Bodmeier, Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems, Journal of Controlled Release, vol.110, issue.2, pp.266-272, 2006.
DOI : 10.1016/j.jconrel.2005.10.005

X. Luan, M. Skupin, J. Siepmann, and R. Bodmeier, Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles, International Journal of Pharmaceutics, vol.324, issue.2, pp.168-175, 2006.
DOI : 10.1016/j.ijpharm.2006.06.004

J. S. Lucks and R. H. Müller, Medication vehicles made of solid lipid particles (solid lipid Nanospheres SLN) EP0000605497, 1991.

H. Maeda, M. Brandon, and A. Sano, Design of controlled-release formulation for ivermectin using silicone, International Journal of Pharmaceutics, vol.261, issue.1-2, pp.9-19, 2003.
DOI : 10.1016/S0378-5173(03)00293-X

M. Martinez, G. Amidon, L. Clarke, W. W. Jones, A. Mitra et al., Applying the biopharmaceutics classification system to veterinary pharmaceutical products Part II. Physiological considerations, Advanced Drug Delivery Reviews, vol.54, issue.6, pp.825-850, 2002.
DOI : 10.1016/S0169-409X(02)00071-6

M. Martinez, L. Augsburger, T. Johnston, and W. W. Jones, Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products Part I: Biopharmaceutics and formulation considerations, Advanced Drug Delivery Reviews, vol.54, issue.6, pp.805-824, 2002.
DOI : 10.1016/S0169-409X(02)00070-4

C. Matschke, U. Isele, P. Van-hoogevest, and A. Fahr, Sustained-release injectables formed in situ and their potential use for veterinary products, Journal of Controlled Release, vol.85, issue.1-3, pp.1-15, 2002.
DOI : 10.1016/S0168-3659(02)00266-3

J. Mauduit, N. Bukh, and M. Vert, Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly (DL-lactic acids), Journal of Controlled Release, vol.25, issue.1-2, pp.43-49, 1993.
DOI : 10.1016/0168-3659(93)90093-K

J. W. Mcginity and P. B. O-'donnell, Preparation of microspheres by the solvent evaporation technique, Advanced Drug Delivery Reviews, vol.28, pp.25-42, 1997.

T. L. Mctier, D. J. Shanks, P. Watson, J. W. Mccall, C. Genchi et al., Prevention of experimentally induced heartworm (Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin, Veterinary Parasitology, vol.91, issue.3-4, pp.259-268, 2000.
DOI : 10.1016/S0304-4017(00)00297-1

. Merck-sanofi-aventis, Creating a Global leader in Animal Health. Call conference 09 march 2010, ) Doc. [En ligne]-Adresse URL, 2010.

J. A. Miller, R. B. Davey, D. D. Oehler, J. M. Pound, J. E. George et al., Control of Boophilus annulatus (Acari: Ixodidae) on Cattle Using Injectable Microspheres Containing Ivermectin, Journal of Economic Entomology, vol.92, issue.5, pp.1142-1146, 1999.
DOI : 10.1093/jee/92.5.1142

J. A. Miller, D. D. Oehler, and J. M. Pound, Delivery of Ivermectin by Injectable Microspheres, Journal of Economic Entomology, vol.91, issue.3, pp.655-659, 1998.
DOI : 10.1093/jee/91.3.655

R. A. Miller, J. M. Brady, and D. E. Cutright, Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios, Journal of Biomedical Materials Research, vol.5, issue.5, pp.711-719, 1977.
DOI : 10.1002/jbm.820110507

R. C. Mundargi, V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi, Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, Journal of Controlled Release, vol.125, issue.3, pp.193-209, 2008.
DOI : 10.1016/j.jconrel.2007.09.013

N. Nihant, C. Grandfils, R. Jerome, and P. Teyssie, Microencapsulation by coacervation of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and encapsulation, Journal of Controlled Release, vol.35, issue.2-3, pp.117-125, 1995.
DOI : 10.1016/0168-3659(95)00026-5

H. Okada, One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.43-70, 1997.
DOI : 10.1016/S0169-409X(97)00050-1

H. Okada, Y. Ogawa, and T. Yashiki, Prolonged release microcapsules and their production, US patent, vol.4652, p.441, 1987.

F. W. Okumu, L. N. Dao, P. J. Fielder, N. Dybdal, D. Brooks et al., Sustained delivery of human growth hormone from a novel gel system: SABERTM, Biomaterials, vol.23, issue.22, pp.4353-4358, 2002.
DOI : 10.1016/S0142-9612(02)00174-6

S. Omura, Ivermectin: 25 years and still going strong, International Journal of Antimicrobial Agents, vol.31, issue.2, pp.91-98, 2008.
DOI : 10.1016/j.ijantimicag.2007.08.023

C. B. Packhaeuser, J. Schnieders, C. G. Oster, and T. Kissel, In situ forming parenteral drug delivery systems: an overview, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.445-455, 2004.
DOI : 10.1016/j.ejpb.2004.03.003

G. F. Palmieri, F. Cantalamessa, D. Martino, P. Nasuti, C. Martelli et al., Lonidamine Solid Dispersions: In Vitro and In Vivo Evaluation, Drug Development and Industrial Pharmacy, vol.61, issue.10, pp.1241-1250, 2002.
DOI : 10.3109/03639049309062990

Y. Pan and R. Cheng, A novel interpretation of concentration dependence of viscosity of dilute polymer solution, Chinese Journal of Polymer Science, vol.18, pp.57-67, 2000.

J. H. Park, M. Ye, and K. Park, Biodegradable Polymers for Microencapsulation of Drugs, Molecules, vol.15, issue.1, pp.146-161, 2005.
DOI : 10.1016/j.jconrel.2003.12.020

T. G. Park, Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition, Biomaterials, vol.16, issue.15, pp.1123-1130, 1995.
DOI : 10.1016/0142-9612(95)93575-X

C. G. Pitt, M. M. Gratzl, and G. L. Kimmel, Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (??-caprolactone), and their copolymers in vivo, Biomaterials, vol.2, issue.4, pp.215-220, 1981.
DOI : 10.1016/0142-9612(81)90060-0

C. G. Pitt and S. S. Shah, Manipulation of the rate of hydrolysis of polymer-drag conjugates: the degree of hydration, Journal of Controlled Release, vol.33, issue.3, pp.397-403, 1995.
DOI : 10.1016/0168-3659(94)00098-F

C. W. Pouton, Formulation of poorly water-soluble drugs for oral administration, 2006.

M. J. Rathbone and M. N. Martinez, Modified release drug delivery in veterinary medicine, Drug Discovery Today, vol.7, issue.15, pp.823-829, 2002.
DOI : 10.1016/S1359-6446(02)02362-0

A. L. Rattes and W. P. Oliveira, Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles, Powder Technology, vol.171, issue.1, pp.7-14, 2007.
DOI : 10.1016/j.powtec.2006.09.007

H. B. Ravivarapu, K. L. Moyer, and R. L. Dunn, Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide, International Journal of Pharmaceutics, vol.194, issue.2, pp.181-191, 2000.
DOI : 10.1016/S0378-5173(99)00371-3

M. I. Ré, MICROENCAPSULATION BY SPRAY DRYING, Drying Technology, vol.1, issue.6, pp.1195-1236, 1998.
DOI : 10.1016/0168-3659(94)90227-5

I. D. Rosca, F. Watari, and M. Uo, Microparticle formation and its mechanism in single and double emulsion solvent evaporation, Journal of Controlled Release, vol.99, issue.2, pp.271-280, 2004.
DOI : 10.1016/j.jconrel.2004.07.007

A. Rothen-weinhold, R. Gurny, and M. Dahn, Formulation and technology aspects of conrolled drug delivery in animals, Pharmaceutical Science & Technology Today, vol.3, issue.7, pp.222-231, 2000.
DOI : 10.1016/S1461-5347(00)00276-5

R. C. Rowe, P. J. Sheskey, and S. C. Owen, Handbook of Pharmaceutical Excipients, 2006.

L. P. Ruan, B. Y. Yu, G. M. Fu, and D. N. Zhu, Improving the solubility of ampelopsin by solid dispersions and inclusion complexes, Journal of Pharmaceutical and Biomedical Analysis, vol.38, issue.3, pp.457-464, 2005.
DOI : 10.1016/j.jpba.2005.01.030

E. Ruel-gariépy and J. C. Leroux, In situ-forming hydrogels???review of temperature-sensitive systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.409-426, 2004.
DOI : 10.1016/j.ejpb.2004.03.019

W. Rungseevijitprapa and R. Bodmeier, Injectability of biodegradable in situ forming microparticle systems (ISM), European Journal of Pharmaceutical Sciences, vol.36, issue.4-5, pp.524-531, 2009.
DOI : 10.1016/j.ejps.2008.12.003

W. Rungseevijitprapa, G. A. Brazeau, J. W. Simkins, and R. Bodmeier, Myotoxicity studies of O/W-in situ forming microparticle systems, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.1, pp.126-133, 2008.
DOI : 10.1016/j.ejpb.2007.10.009

P. Sansdrap and A. J. Moes, Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres, International Journal of Pharmaceutics, vol.98, issue.1-3, pp.157-164, 1993.
DOI : 10.1016/0378-5173(93)90052-H

O. Sartor, Eligard: leuprolide acetate in a novel sustained-release delivery system, Urology, vol.61, issue.2, pp.25-31, 2003.
DOI : 10.1016/S0090-4295(02)02396-8

J. M. Schakenraad, J. A. Oosterbaan, P. Nieuwenhuis, I. Molenaar, J. Olijslager et al., Biodegradable hollow fibres for the controlled release of drugs, Biomaterials, vol.9, issue.1, pp.116-120, 1988.
DOI : 10.1016/0142-9612(88)90082-8

S. Schenderlein, M. Lück, and B. W. Müller, Partial solubility parameters of poly(d,l-lactide-co-glycolide), International Journal of Pharmaceutics, vol.286, issue.1-2, pp.19-26, 2004.
DOI : 10.1016/j.ijpharm.2004.07.034

J. C. Shah, Y. Sadhale, and D. M. Chilukuri, Cubic phase gels as drug delivery systems, Advanced Drug Delivery Reviews, vol.47, issue.2-3, 2001.
DOI : 10.1016/S0169-409X(01)00108-9

N. H. Shah, A. S. Railkar, F. C. Chen, R. Tarantino, S. Kumar et al., A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers, Journal of Controlled Release, vol.27, issue.2, pp.139-147, 1993.
DOI : 10.1016/0168-3659(93)90217-S

S. S. Shah, Y. Cha, and C. G. Pitt, Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery?, Journal of Controlled Release, vol.18, issue.3, pp.261-270, 1992.
DOI : 10.1016/0168-3659(92)90171-M

M. L. Shively, B. A. Coonts, W. D. Renner, J. L. Southard, and A. T. Bennett, Physico-chemical characterization of a polymeric injectable implant delivery system, Journal of Controlled Release, vol.33, issue.2, pp.237-243, 1995.
DOI : 10.1016/0168-3659(94)00097-E

R. A. Siegel and B. A. Firestone, pH-dependent equilibrium swelling properties of hydrophobic polyelectrolyte copolymer gels, Macromolecules, vol.21, issue.11, pp.3254-3259, 1988.
DOI : 10.1021/ma00189a021

J. Siepmann, K. Elkharraz, F. Siepmann, and D. Klose, How Autocatalysis Accelerates Drug Release from PLGA-Based Microparticles:?? A Quantitative Treatment, Biomacromolecules, vol.6, issue.4, pp.2312-2319, 2005.
DOI : 10.1021/bm050228k

A. Smith and I. M. Hunneyball, Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration, International Journal of Pharmaceutics, vol.30, issue.2-3, pp.215-220, 1986.
DOI : 10.1016/0378-5173(86)90081-5

E. B. Souto and R. H. Müller, Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes, Handbook of Experimental Pharmacology, pp.115-141, 2010.
DOI : 10.1007/978-3-642-00477-3_4

D. Steinberg and M. Friedman, Dental Drug-Delivery Devices: Local and Sustained-Release Applications, Critical Reviews?? in Therapeutic Drug Carrier Systems, vol.16, issue.5, pp.425-459, 1999.
DOI : 10.1615/CritRevTherDrugCarrierSyst.v16.i5.10

R. G. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004.
DOI : 10.1023/B:PHAM.0000016235.32639.23

S. Kas, H. Ôner, and L. , Microencapsulation using Coacervation/Phase separation: An overview of the technique and applications Handbook of Pharmaceutical Controlled Release Technology, pp.301-328, 2000.

Y. Sun, D. W. Scruggs, Y. Peng, J. R. Johnson, and A. J. Shukla, Issues and challenges in developing long-acting veterinary antibiotic formulations, Advanced Drug Delivery Reviews, vol.56, issue.10, pp.1481-1496, 2004.
DOI : 10.1016/j.addr.2004.02.009

C. Sundback, T. Hadlock, M. Cheney, and J. Vacanti, Manufacture of porous polymer nerve conduits by a novel low-pressure injection molding process, Biomaterials, vol.24, issue.5, pp.819-830, 2003.
DOI : 10.1016/S0142-9612(02)00409-X

K. Suzuki and J. C. Price, Microencapsulation and Dissolution Properties of a Neuroleptic in a Biodegradable Polymer, Poly(d,l-lactide), Journal of Pharmaceutical Sciences, vol.74, issue.1, pp.21-24, 1985.
DOI : 10.1002/jps.2600740106

I. Teraoka, Polymer solutions: An introduction to physical properties, 2002.
DOI : 10.1002/0471224510

C. Thomasin, H. P. Merkle, and B. Gander, Drug Microencapsulation by PLA/PLGA Coacervation in the Light of Thermodynamics. 2. Parameters Determining Microsphere Formation, Journal of Pharmaceutical Sciences, vol.87, issue.3, 1998.
DOI : 10.1021/js970048j

T. R. Tice and D. R. Cowsar, Biodegradable controlled-release parenteral systems, Pharmaceutical Technology, vol.8, 1984.

A. J. Tipton and J. Richard, Southern Biosystems, Inc.High viscosity liquid controlled delivery system, US Patent, vol.5747, p.58, 1998.

K. E. Uhrich, S. M. Cannizzaro, R. S. Langer, and K. M. Shakesheff, Polymeric Systems for Controlled Drug Release, Chemical Reviews, vol.99, issue.11, pp.3181-3198, 1999.
DOI : 10.1021/cr940351u

J. Smid, J. Olijslager, J. M. Schakenraad, M. J. Eenink, and A. P. Sam, Formation of porous membranes for drug delivery systems, Journal of Controlled Release, vol.24, pp.61-78, 1993.

J. Varshosaz, M. Minayian, and E. Moazen, Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles, Journal of Liposome Research, vol.45, issue.1, pp.115-123, 2010.
DOI : 10.1016/S0939-6411(97)00150-1

R. Verrijk, I. J. Smolders, N. Bosnie, and A. C. Begg, Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide, Cancer Research, vol.52, pp.6653-6656, 1992.

C. Volland, M. Wolff, and T. Kissel, The influence of terminal gamma-sterilization on captopril containing poly(d,l-lactide-co-glycolide) microspheres, Journal of Controlled Release, vol.31, issue.3, pp.293-304, 1994.
DOI : 10.1016/0168-3659(94)90012-4

L. Wang, S. Venkatraman, and L. Kleiner, Drug release from injectable depots: two different in vitro mechanisms, Journal of Controlled Release, vol.99, issue.2, pp.207-216, 2004.
DOI : 10.1016/j.jconrel.2004.06.021

G. Winzenburg, C. Schmidt, S. Fuchs, and T. Kissel, Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems, Advanced Drug Delivery Reviews, vol.56, issue.10, pp.1453-1466, 2004.
DOI : 10.1016/j.addr.2004.02.008

C. Wischke and S. P. Schwendeman, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, International Journal of Pharmaceutics, vol.364, issue.2, pp.298-327, 2008.
DOI : 10.1016/j.ijpharm.2008.04.042

D. L. Wise, Handbook of Pharmaceutical Controlled Release Technology, 2000.

C. Witschi and E. Doelker, Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing, Journal of Controlled Release, vol.51, issue.2-3, pp.327-341, 1998.
DOI : 10.1016/S0168-3659(97)00188-0

S. Yang, K. F. Leong, Z. Du, and C. K. Chua, The Design of Scaffolds for Use in Tissue Engineering. Part I. Traditional Factors, Tissue Engineering, vol.7, issue.6, pp.679-689, 2001.
DOI : 10.1089/107632701753337645

X. Zhang, U. P. Wyss, D. Pichora, M. F. Goosen, A. Gonzal et al., Controlled release of testosterone and estradiol-17 ?? from biodegradable cylinders, Journal of Controlled Release, vol.29, issue.1-2, pp.157-161, 1994.
DOI : 10.1016/0168-3659(94)90131-7

B. S. Zolnik and D. J. Burgess, Evaluation of in vivo???in vitro release of dexamethasone from PLGA microspheres, Journal of Controlled Release, vol.127, issue.2, pp.137-145, 2008.
DOI : 10.1016/j.jconrel.2008.01.004